Influence of xantinole nicotinic acid on cutaneous microcirculation in patients with coronary artery disease and hyperlipoproteinemia

Clinical Hemorheology and Microcirculation

Volumn 39, Issue 1-4, 2008, Pages 287-292

  Leithauser B ^a   Gerk, U ^b   Mrowietz, C ^c   Jung, F ^c   Park, J W ^b  

^a Clinic for Angiology   (Germany)

^b Institute for Heart and Circulation Research   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Coronary artery disease; Microcirculation; Naifold capillary microscopy; Nicotinic acid; Reactive hyperemia

Indexed keywords

XANTHINOL NICOTINATE;

AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DISEASE DURATION; DRUG EFFECT; ERYTHROCYTE; FEMALE; FLUSHING; HEART RATE; HUMAN; HYPEREMIA; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; ISCHEMIA; MALE; MEASUREMENT; MICROCIRCULATION; MICROSCOPY; OPEN STUDY; PILOT STUDY; SKIN BLOOD FLOW; STATISTICAL SIGNIFICANCE; TIME;

AGED; BLOOD PRESSURE; CAPILLARIES; CORONARY ARTERY DISEASE; FEMALE; HEART RATE; HUMANS; HYPERLIPOPROTEINEMIAS; LIPOPROTEINS; MALE; MICROCIRCULATION; MIDDLE AGED; NIACIN; PILOT PROJECTS; SKIN;

EID: 47849099588     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2008-1091     Document Type: Conference Paper

References (24)

1. R. Altschul, A. Hoffer and J.D. Stephen, Influence of nicotinic acid on serum cholesterol in man, Arch. Biochem. 54 (1955), 558-559.
2. Third report of the National Cholesterol Education Program (NCEP), Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report, Circulation 106 (2002), 3143-3421.
3. P. de Nicola and G. Tassi, Microcirculation in the conjunctiva and the nail bed in the aged. Symptomatic and clinicopharmacologic aspects, Minerva Med. 73 (1982), 3251-3262.
4. I.S. Vesel'skii and A.V. Sanik, The correction of microcirculatory disorders in patients with circulatory encephalopathy, Vrach. Delo (1991), 85-87.
5. A. Creutzig and K. Alexander, Drug-induced alterations in muscle tissue oxygen pressure in patients with arterial occlusive disease, Int. J. Microcirc. Clin. Exp. 4 (1985), 173-181.
6. A. Scheffler, Medikamentöse Vasodilatation bei peripherer arterieller Verschlußkrankheit - Eine alte Kontroverse, in: Aktuelle Therapieprinzipien bei der peripheren arteriellen Verschlußkrankheit: Symposium, H. Landgraf, ed., Vieweg, Braunschweig, 1991, 159-178.
7. G.B. Yvonne-Tee, A.H. Rasool, A.S. Halim and A.R. Rahman, Noninvasive assessment of cutaneous vascular function in vivo using capillaroscopy, plethysmography and laser-Doppler instruments: its strengths and weaknesses, Clin. Hemorheol. Microcirc. 34 (2006), 457-473.
8. T. Klyscz, M. Jünger, F. Jung and H. Zeintl, Cap image - a new kind of computer-assisted video image analysis system for dynamic capillary microscopy, Biomed. Tech. 42 (1997), 168-175.
9. E.G. Salerud, T. Tenland, G.E. Nilsson and P.A. Oberg, Rhythmical variations in human skin blood flow, Int. J. Microcirc. Clin. Exp. 2 (1983), 91-102.
10. J. Ostergren and B. Fagrell, Skin capillary blood cell velocity in patients with arterial obliterative disease and polycythaemia: a disturbed reactive hyperaemia response, Clin. Physiol. 5 (1985), 35-43.
11. F. Jung, H. Toonen, C. Mrowietz, S. Wolf, H. Kiesewetter, E. Wenzel et al., Error analysis, biological modification factors and variance of peri-ungual video-capillary microscopy, Biomed. Tech. (Berlin) 35 (1990), 195-204.
12. J.D. Morrow, W.G. Parsons, III and L.J. Roberts, Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid, Prostaglandins 38 (1989), 263-274.
13. L. Kaijser and A. Wennmalm, Nicotinic acid stimulates prostaglandin synthesis in the rabbit heart without releasing noradrenaline, Acta Physiol. Scand. 102 (1978), 246-247.
14. V. Saareks, I. Mucha, E. Sievi and A. Riutta, Nicotinic acid and pyridoxine modulate arachidonic acid metabolism in vitro and ex vivo in man, Pharmacol. Toxicol. 84 (1999), 274-280.
15. A.G. Olsson, L.A. Carlson, E. Anggard and G. Ciabattoni, Prostacyclin production augmented in the short term by nicotinic acid, Lancet 2 (1983), 565-566.
16. A. Koller and G. Kaley, Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation, Circ. Res. 67 (1990), 529-534.
17. M. Minamiyama, T. Minato, A. Yamamoto, T. Kaihatsu and K. Tsunoda, Effects of carpronium chloride on the microvascular blood flow in rat mesentery using intravital videomicroscopy, Clin. Hemorheol. Microcirc. 34 (2006), 125-129.
18. Z. Benyo, A. Gille, C.L. Bennett, B.E. Clausen and S. Offermanns, Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells, Mol. Pharmacol. 70 (2006), 1844-1849.
19. F. Jung, M. Wappler, H.P. Nuttgens, H. Kiesewetter, S. Wolf and G. Muller, Method of video capillary microscopy: determination of geometric and dynamic measuring parameters, Biomed. Tech. (Berlin) 32 (1987), 204-213.
20. R.G. Andersson, G. Aberg, R. Brattsand, E. Ericsson and L. Lundholm, Studies on the mechanism of flush induced by nicotinic acid, Acta Pharmacol. Toxicol. (Copenhagen) 41 (1977), 1-10.
21. Coronary Drug Project Research Group, Clofibrate and niacin in coronary heart disease, JAMA 231 (1975), 360-381.
22. A. Subissi, M. Bachi and P. Brunori, Some cardiovascular effects of LG 13979: comparison with nicotinic acid and other nicotinic acid derivatives, J. Pharm. Pharmacol. 35 (1983), 612-614.
23. S.D. Turenne, M. Seeman and B.M. Ross, An animal model of nicotinic-acid-induced vasodilation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response, Schizophr. Res. 50 (2001), 191-197.
24. K. Cheng, T.J. Wu, K.K. Wu, C. Sturino, K. Metters, K. Gottesdiener et al., Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans, Proc. Natl. Acad. Sci. USA 103 (2006), 6682-6687.